New Key Statistics Module, Z-Score and F-Score
NAS:MRNS Key Ratios
Market Cap $ M | 70.86 |
Enterprise Value $ M | 35.17 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 2.53 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 28.00 |
EPS (TTM) $ | -2.64 |
Beneish M-Score | -3.94 |
10-y EBITDA Growth Rate % | 16.90 |
5-y EBITDA Growth Rate % | 29.50 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.27 |
EV-to-EBITDA | -0.27 |
PEG | -- |
Shares Outstanding M | 54.93 |
Net Margin (%) | -513.80 |
Operating Margin % | -474.91 |
Pre-tax Margin (%) | -519.24 |
Quick Ratio | 2.93 |
Current Ratio | 3.07 |
ROA % (ttm) | -77.55 |
ROE % (ttm) | -368.35 |
ROIC % (ttm) | -851.62 |
Dividend Yield % | -- |
Altman Z-Score | -8.08 |
MRNS Number of Guru Trades
MRNS Volume of Guru Trades
Gurus Latest Trades with NAS:MRNS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:MRNS is held by these investors
Total 1
Marinus Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:MRNS
Total 0- 1